baber/WOPTO huggingface dataset:
Patent NZ-588043-A (NZ)
Title: Filter vial and liquid extraction piston with mechanical seal
Inventor: ELLIS SAMUEL A
IPC: A61J1/00
Filed: 2009-02-20
Abstract: Disclosed is a tubular piston for a filter vial assembly, wherein the filter vial assembly includes a tubular vial with an open proximal end and a closed distal end and a cylindrical sidewall of diameter D. The piston includes a longitudinal axis and opposing proximal and distal ends and a cup covering the distal end of the tubular piston, the cup having a proximal cup seal engages the walls of the vial to form a fluid tight seal when the piston is advanced into the vial. The piston flange extends away from the longitudinal axis at the distal end the piston and located adjacent a recess in the tubular piston so the cup forms a snap fit over the piston flange and extends into the recess, the piston flange causes the cup to bulge sufficiently outward to form a fluid tight cup seal with the vial when the flange and cup are inserted into the vial. The tubular piston and cup each further include a porous bottom through which fluid can flow during use. The cup includes a continuous sidewall overlapping the distal end of the tubular piston. The sidewall is flexible to deform around the piston flange to achieve a diameter greater than D in a plane orthogonal to the longitudinal axis and through the piston flange but small enough in diameter to fit in the open end of the filter vial. The cup also has a lip and flange that each extend around the cup.
Patent NZ-588155-A (NZ)
Title: Dynamic currency conversion transaction system
Inventor: SHARMA SUNIL
IPC: G06Q20/00
Filed: 2010-09-23
Abstract: 588155 Disclosed is a computer-implemented method of performing an Integrated Circuit Card (ICC) transaction between a card holder and a merchant in the currency of the card issuer (Issuing Bank A or B). The method including the steps of obtaining a card-issuer currency from data present on the ICC (26) and, if the issuer currency is not the same as the merchant currency, determining the transaction amount in the issuer currency. The method also includes providing the transaction in the card issuer currency for authorisation. The step of obtaining the issuer currency includes the steps of searching ICC data for one or more predetermined fields and retrieving data relating to one or more of the fields. The issuer currency is obtained without first identifying the issuer (Issuing Bank A or B) of the card (26).
Patent NZ-589084-A (NZ)
Title: Glucokinase activators
Inventor: CHERUVALLATH ZACHARIA
IPC: A61K31/4155
Filed: 2009-05-15
Abstract: Disclosed are pyrazole-amide compounds represented by general formula (I). Examples of the compounds of formula (I) include: 2-(3-(cyclopropylsulfonyl)-1H-pyrazol-1-yl)-N-(5-methoxythiazolo[5,4-b ]pyridin-2-yl)-3-(tetrahydro-2H-pyran-4-yl)propanamide; (S)-2-(3-(cyclopropylsulfonyl)-1H-pyrazol-1-yl)-N-(5-methoxythiazolo[5,4-b ]pyridin-2-yl)-3-(tetrahydro-2H-pyran-4-yl)propanamide; and (R)-2-(3 -(cyclopropylsulfonyl)-1H-pyrazol-1-yl)-N-( 5-methoxythiazolo[5,4-b]pyridin-2-yl)-3-( tetrahydro-2H-pyran-4-yl)propanamide. The compounds are used to treat hyperglycemia, diabetes, dyslipidaemia, obesity, insulin resistance, metabolic syndrome, impaired glucose tolerance, polycystic ovary syndrome and cardiovascular disease.
Patent NZ-589190-A (NZ)
Title: Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes
Inventor: GOUGOUTAS JACK Z
IPC: A61K31/70
Filed: 2007-06-21
Abstract: Disclosed is a crystalline structure of a (1S)-1,5-anhydro-1-C-(3-((phenyl) methyl) phenyl)-D-glucitol of formula 1c. Also disclosed is the use of said form for treating diabetes, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids or glycerol, hyperlipidemia, dyslipidemia, obesity, hypertriglyceridemia, or diabetic complications.
Patent NZ-594210-A (NZ)
Title: Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
Inventor: MULLINGER BERNHARD
IPC: A61K9/00
Filed: 2010-02-03
Abstract: Abstract 594210 Disclosed are methods, devices and compositions for treatment of severe and uncontrolled asthma by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse effects.
Patent NZ-595037-A (NZ)
Title: Inhibition of biofilm organisms by combination of cysteamine and repetitive peptides
Inventor: O NEIL DEBORAH
IPC: A61K38/08
Filed: 2010-03-31
Abstract: 595037 INHIBITION OF BIOFILM ORGANISMS Provided is the use of cysteamine to treat microbial infections, including biofilm infections. Also provided is a product comprising at least two antibiofilm agents wherein at least one of the antibiofilm agents is an antimicrobial peptide and the at least one other antibiofilm agent is cysteamine wherein the antimicrobial peptide comprises 5 amino acids according to the formula ((X)l(Y)m)n wherein l and m are integers from 1 to 10, or from 1 to 5; n is an integer from 1 to 10; X and Y, which may be the same or different, are independently a hydrophobic or cationic amino acid. The amino acids may be histidine, arginine and lysine.
Patent NZ-597249-A (NZ)
Title: Wrapped optoelectronic devices and methods for making same
Inventor: CURRAN SEAMUS
IPC: H01L51/52
Filed: 2010-06-15
Abstract: 597249 Disclosed is an optoelectronic device. The optoelectronic device has a panel with a first conductive layer that has a first patterning so as to form a plurality of first electrodes. The panel also includes a semi-conductive layer disposed over and in electrical communication with the first conductive layer. The device further includes a second conductive layer disposed over and in electrical communication with the semi-conductive layer and has a second patterning so as to form a plurality of second electrodes. The first patterning of the first conductive layer and the second patterning of the second conductive layer forms a linear pixel array with each pixel defined only by an area of a cathode overlapping an anode. The panel is arranged so as to extend around a central axis with a region of one of the first and second conductive layers disposed radially outwardly of a corresponding region of the other of the first and second conductive layers.
Patent NZ-598302-A (NZ)
Title: Molecule production by photosynthetic organisms
IPC: C07K14/02
Filed: 2008-09-10
Abstract: A method of increasing phytol production in a non-vascular photosynthetic organism, comprising: transforming said organism with a nucleic acid which results in an increase in production of phytol by said organism above a level produced by the host cell not containing said nucleic acid wherein said nucleic acid encodes an enzyme selected from the group consisting of a GPP synthase, a FPP synthase, a geranylgeranyl reductase, a chlorophyllidohydrolase, and a pyrophosphatase; and further comprising transformation of said organism with a nucleic acid which results in production of dimethylallyl alcohol, isopentyl alcohol, geraniol, farnesol or geranylgeraniol.
Patent NZ-615182-A (NZ)
Title: Blade sharpener
Inventor: JASON COOPER
IPC: B24D15/08
Filed: 2013-09-05
Abstract: 615182 Disclosed are a blade sharpener (10) and a method for assembling a blade sharpener (10). The blade sharpener (10) is configured to facilitate single-handed sharpening of bladed hand tools such as a knife or a pair of scissors. The blade sharpener (10) suitable for manually maintaining an edge of a bladed hand tool comprises a base (16); a blade sharpening assembly (50) and a cover (14). The base (16) carries a selectively operable retaining mechanism (18). The retaining mechanism (18) has an attachment device (62) for releasably retaining the blade sharpener (10) on a surface. The blade sharpening assembly (50) is located in the base (16) and includes at least two sharpening heads (52, 54). The at least two sharpening heads (52, 54) are disposed adjacent to one another in overlapping relation to form a generally “V” shaped configuration. The cover (14) is removably fastened to the base (16). The cover (14) includes a slotted opening through which the heads of the blade sharpening assembly (50) protrude and including at least two head support portions. The at least two head support portions are disposed at the slotted opening for supporting respective sharpening heads. Each head support portion is positioned adjacent to a respective sharpening head (52, 54) and offset in a blade sharpening direction from an opposing head support portion. The head support portions extend laterally of a blade sharpening direction
Patent NZ-615194-A (NZ)
Title: Methods for improving bone health in infants using prebiotics
Inventor: PEDROSA JOSE MARIA LOPEZ
IPC: A61P19/00
Filed: 2012-03-20
Abstract: Disclosed is the use of a prebiotic in the manufacture of a medicament for improving bone health, increasing bone strength, or promoting bone formation in an infant, where the medication is a nutritional formulation administered to a pregnant woman.
Patent NZ-620799-A (NZ)
Title: Molecular diagnostic test for cancer
Inventor: O’DONNELL JUDE
IPC: G01N33/48
Filed: 2011-09-15
Abstract: Discloses a method of predicting responsiveness of an individual to a DNA-damage therapeutic agent or diagnosing an individual for having a cancer associated with a DNA damage response deficiency (DDRD) comprising a. measuring expression levels of at least five biomarkers in a test sample obtained previously from the individual, wherein the at least five biomarkers are selected from the 44 biomarkers of Table 2B and further measuring the expression level of at least one or more additional biomarkers that are not from Table 2B in the test sample; b. deriving a combined test score that captures the combined increased expression level of the at least five biomarkers and the one or more additional biomarkers in the test sample; c. providing a threshold score comprising information correlating the test score and responsiveness; d. and comparing the combined test score to the threshold score; wherein responsiveness to a DNA-damage therapeutic agent is predicted when the combined test score exceeds the threshold score.
Patent NZ-630281-A (NZ)
Title: Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
Inventor: HAUPT ANDREAS
IPC: C07D405/14
Filed: 2013-10-21
Abstract: The present disclosure relates to acylaminocycloalkyl compounds of the formula (I) as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor. In formula (I), the variables have the following meanings: m is 1 or 2, n is 1 or 2, A is selected from the group consisting of CH2, CH2CH2, CHFCH2 and CF2CH2, R1 is hydrogen or C1-C3-alkyl, R2 is selected from the group consisting of hydrogen, and fluorine, R3a is selected from the group consisting of hydrogen and methyl, R3b is selected from the group consisting of hydrogen and methyl, R4 is branched C4-C6 alkyl or branched fluorinated C4-C6 alkyl, and R5 is an oxygen containing radical such as C1-C2-alkoxy-C1-C4-alkyl, fluorinated C1-C2-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkyl, fluorinated hydroxy-C1-C4-alkyl, oxetanyl, fluorinated oxetanyl, oxolanyl, fluorinated oxolanyl, C3-C5 cycloalkyl, fluorinated C3-C5 cycloalkyl, C3-C5 cycloalkoxy-C1-C4-alkyl and fluorinated C3-C5 cycloalkoxy-C1-C4-alkyl. Examples of disease treated include: disorder or condition of the central nervous system, Parkinson’s disease, schizophrenia, bipolar disorder, depression, motivation disturbances, anxiety, cognitive dysfunction, pain, disorder associated with drug abuse, eating disorders, renal function disorders and diabetic nephropathy.
Patent NZ-701717-A (NZ)
Title: Adjusting device for turbine rotor blades
Inventor: ERICH WURM
IPC: F03B3/14
Filed: 2014-11-06
Abstract: ABSTRACT The invention relates to an adjusting device for turbine rotor blades (2) mounted on a hub, where a hydraulic servo-cylinder is provided as well as another servo-cylinder. It is largely characterized in that one end of the adjusting rods (7, 8) of the servo-cylinders is swivel mounted at the adjusting crank (9) rigidly connected to the axis of the rotor blade (2). With this arrangement, adjustments, i.e. rotations, through 360° are also possible. Here, the bearings (13, 14) of the adjusting rods (7, 8) can be arranged eccentrically, i.e. outside the rotating axis (17) of the hub. Alternatively, an auxiliary servo-cylinder is provided in addition to the main servo-cylinder and is arranged opposite the main servo-cylinder, while its adjusting rod (8) is disposed on the adjusting crank (9) opposite the adjusting rod (7) of the main servo-cylinder and offset. Thus, adjustment beyond 180° is also possible and the dead center of the adjusting rod (7) of the main servo-cylinder, which lies between the two, can be overcome. In this way, the dead centers of the servo-cylinders can be overcome, while there is always at least one cylinder available to apply the necessary force.
Patent NZ-702007-A (NZ)
Title: Method and system for predicting energy on target
Inventor: DAVIS WILLIAM H
IPC: H04W52/24
Filed: 2013-05-03
Abstract: A method for modifying a design of an RF transmitter, comprising: receiving input information specifying a transmitter platform model to be used as a transmitter for an energy-on-target analysis; receiving input information specifying a receiver platform model to be used as a receiver for the energy-on-target analysis; receiving input information specifying a propagation model to be used for a channel between the transmitter and the receiver for the energy-on-target analysis; receiving input information specifying a number of receiver locations for which energy-on-target information is desired; receiving input information specifying a transmit antenna model; receiving input information specifying a location of a transmitter platform; receiving input information specifying an attitude of the transmitter platform; orienting the transmit antenna model with respect to the transmitter platform to generate an oriented transmit antenna model; calculating an Effective Isotropic Radiated Power (EIRP) using the transmitter platform model and the oriented transmit antenna model; orienting the transmitter platform model with respect to a surrounding area based on the location of the transmitter platform and the attitude of the transmitter platform to generate an oriented transmitter platform model; performing a series of link analyses for the number of receiver locations using the oriented transmitter platform model, the receiver platform model, and the channel propagation model, wherein each link analysis in the series of link analyses determines a receive power level at a corresponding receiver location taking into consideration transmit power level, transmit and receive antenna gain at the corresponding receiver location, propagation power loss in the channel, and polarization loss at the corresponding receiver location; and modifying the design of the RF transmitter based on the results of the series of link analyses.
Patent NZ-707754-A (NZ)
Title: Combination of glycopyrrolate and a beta2 -agonist
Inventor: MALHOTRA GEENA
IPC: A61P11/06
Filed: 2012-02-17
Abstract: Provided are pharmaceutical compositions comprising glycopyrrolate, a beta2-adrenergic agonist, and optionally a corticosteroid. Preferred beta2-adrenergic agonists include indacaterol, formoterol, vilanterol, carmoterol and olodaterol. Preferred corticosteroids include fluticasone and mometasone. Particularly preferred compositions consist of glycopyrrolate, formoterol fumarate dihydrate and fluticasone furoate; glycopyrrolate, vilanterol trifenatate and fluticasone furoate; or glycopyrrolate and olodaterol hydrochloride monohydrate. The compositions can be used in the treatment of respiratory, inflammatory or obstructive airway diseases.
Patent NZ-714039-A (NZ)
Title: Decoding method and decoding apparatus
Inventor: WANG BIN
IPC: G10L21/0388
Filed: 2014-05-09
Abstract: A decoding method and a decoding device. The decoding method comprises: in the case where a current frame is determined as a lost frame, synthetizing a high-frequency band signal according to a decoding result of a previous frame (110); according to a subframe gain of subframes of at least one frame before the current frame and a gain gradient between subframes of the above-mentioned at least one frame, determining the subframe gain of a plurality of subframes of the current frame (120); determining a global gain of the current frame (130); and according to the global gain and the subframe gain of the plurality of subframes, adjusting the synthetized high-frequency band signal to obtain a high-frequency band signal of the current frame (140). Since the subframe gain of the current frame is obtained according to the subframe gain gradient of the subframe before the current frame, the transition before and after losing the frame has a better continuity, thereby reducing the reconstruction signal noise, and improving the voice quality.
Patent NZ-718201-A (NZ)
Title: Hydrochloride salt form for ezh2 inhibition
Inventor: KUNTZ KEVIN W
IPC: C07D413/12
Filed: 2014-10-15
Abstract: Provided herein are novel solid forms of N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5 -(ethyl (tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4’-(morpholinomethyl)-[1,1’-biphenyl]-3-carboxamide hydrochloride, and related compositions and methods, and its use as an inhibitor of histone methyltransferase activity of EZH2 for the treatment of EZH2-mediated cancers such as B cell lymphoma, non-Hodgkin’s lymphoma and breast cancer.
Patent NZ-719776-A (NZ)
Title: Synergistic pesticidal compositions and related methods
Inventor: GOMEZ LUIS E
IPC: A01N43/56
Filed: 2014-10-17
Abstract: A pesticidal composition comprises a synergistically effective amount of a nicotinic acetylcholine receptor (nAChR) agonist compound and a pesticide selected from N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-3-((3,3,3- trifluoropropyl)thio)propanamide (I), N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N- ethyl-3-((3,33-trifluoropropyl)sulfinyl) propanamide (II), or any agriculturally acceptable salt thereof. A method of controlling pests comprises applying the pesticidal composition near a population of pests. A method of protecting a plant from infestation and attack by insects comprises contacting the plant with the synergistic pesticidal composition.
Patent NZ-721008-A (NZ)
Title: A method of manufacturing a rigid cage enclosure
Inventor: HURBANS SINGH
IPC: F21V15/02
Filed: 2016-06-10
Abstract: In one aspect the invention provides a method of manufacturing a rigid cage enclosure starting with a sheet of source material with a thickness desirable for the sidewall thickness of the enclosure to be formed. Material is removed from or deformed on the surface of the sheet to form a series of encircling tracks which define a series of void regions. The sheet is then bent into an enclosure which defines an open top face and an open bottom face with the sheet defining at least one sidewall of the enclosure. The ends of the sheet are joined together to close the enclosure and connect the sidewall or walls of the enclosure together while the material defining the void regions is removed to form an array of beams.
Patent NZ-724339-A (NZ)
Title: Agricultural baler with auxiliary power system powered by movable component(s) on the baler
Inventor: VERHAEGHE DIDIER
IPC: A01F15/08
Filed: 2015-07-07
Abstract: An agricultural baler (10) includes a flywheel (44), a driveline (50) associated with the flywheel (44) and couplable with a power take-off (PTO) of a traction unit, and a movable component (100) which is driven directly or indirectly by the driveline (50) and movable in a linear and/or rotational manner. The baler is characterized by an auxiliary power system (52) coupled with the movable component (100). The auxiliary power system (52) is configured for receiving power from the movable component (100) and storing the power.
Patent NZ-729754-A (NZ)
Title: Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
Inventor: ZAGER RICHARD
IPC: A61K38/41
Filed: 2015-09-28
Abstract: The present disclosure provides compositions, kits, and methods to protect organs by inducing acquired cytoresistance without causing injury to the organ. The compositions, kits, and methods utilize heme proteins, iron and/or vitamin B12 and, optionally, agents that impact heme protein metabolism. Said methods comprise administration of a combination of: (i) Myoglobin or iron (III) (iron sucrose) (ii) a heme protein degradation inhibitor (such as tin protoporphyrin) Components (i) and (ii) have a synergistic effect that results in protective effects, protecting the organ in several injury models
Patent NZ-733920-A (NZ)
Title: System and method for preparing high-purity vanadium pentoxide powder
Inventor: ZHU QINGSHAN
IPC: C01G31/04
Filed: 2016-01-28
Abstract: The present invention provides a system and method for preparing high-purity vanadium pentoxide powder. Industrial grade vanadium pentoxide is converted to vanadium oxytrichloride by low temperature fluidizing chlorination, wherein chlorinating gas is preheated via heat exchange between fluidizing gas and chlorination flue gas, and an appropriate amount of air is added to enable a part of carbon powder to combust so as to achieve a balanced heat supply during the chlorination, thereby increasing the efficiency of chlorination and ensuring good selectivity in low temperature chlorination. The vanadium oxytrichloride is subjected to purification by rectification, ammonium salt precipitation and fluidized calcination, thereby obtaining high-purity vanadium pentoxide, wherein the ammonia gas produced during calcination is condensed and then recycled for ammonium salt precipitation.
Patent NZ-740049-A (NZ)
Title: Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
Inventor: JANG MYUNG HYUN
IPC: C07K14/605
Filed: 2012-06-07
Abstract: Disclosed is a peptide comprising the amino acid sequence of SEQ ID NO:28 (HXQGTFTSDYSKYLDEKRAKEFVQWLMNT) but not comprising SEQ ID NO:28 (HXQGTFTSDYSKYLDEKRAKEFVQWLMNTC) for the manufacture of a medicament for the prevention or treatment of obesity in a subject at risk of obesity or having obesity.
Patent NZ-748259-A (NZ)
Title: Sealing gland
Inventor: HAYNES ANDREW LEO
IPC: F16L7/02
Filed: 2005-10-27
Abstract: A sealing gland is for sealing around outer surfaces of concentric elongate members, typically pipes, and has a frusto-conical part and a cylindrical part. The frusto-conical part typically has markings to enable different end diameters to be cut to match different pipe diameters. Each part deforms to seal about a respective pipe portion. Other embodiments are disclosed such as sealing a pipe projecting from a wall.